Little Rock, AR27 Active Studies

Ankylosing Spondylitis Clinical Trials in Little Rock, AR

Find 27 actively recruiting ankylosing spondylitis clinical trials in Little Rock, AR. Connect with local research sites and explore new treatment options.

27
Active Trials
21
Sponsors
64,172
Enrolling

Recruiting Ankylosing Spondylitis Studies in Little Rock

About Ankylosing Spondylitis Clinical Trials in Little Rock

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 27 ankylosing spondylitis clinical trials recruiting participants in Little Rock, AR. These studies are seeking a combined 64,172 participants. Research is being sponsored by Pfizer, Amgen, Genzyme, a Sanofi Company and 18 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Little Rock — FAQ

Are there ankylosing spondylitis clinical trials in Little Rock?

Yes, there are 27 ankylosing spondylitis clinical trials currently recruiting in Little Rock, AR. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Little Rock?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Little Rock research site will contact you about next steps.

Are clinical trials in Little Rock free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Little Rock studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 27 active trials in Little Rock are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 19, 2026 from ClinicalTrials.gov